Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting GOF p53 and c-MYC through LZK Inhibition or Degradation Suppresses Head and Neck Tumor Growth.
Funk AL, Katerji M, Afifi M, Nyswaner K, Woodroofe CC, Edwards ZC, Lindberg E, Bergman KL, Gough NR, Rubin MR, Karpińska K, Trotter EW, Dash S, Ries AL, James A, Robinson CM, Difilippantonio S, Karim BO, Chang TC, Chen L, Xu X, Doroshow JH, Ahel I, Marusiak AA, Swenson RE, Cappell SD, Brognard J. Funk AL, et al. Among authors: rubin mr. bioRxiv [Preprint]. 2024 Nov 20:2024.11.19.623840. doi: 10.1101/2024.11.19.623840. bioRxiv. 2024. PMID: 39605563 Free PMC article. Preprint.
PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.
Torres-Ayuso P, Katerji M, Mehlich D, Lookingbill SA, Sabbasani VR, Liou H, Casillas AL, Chauhan SS, Serwa R, Rubin MR, Marusiak AA, Swenson RE, Warfel NA, Brognard J. Torres-Ayuso P, et al. Among authors: rubin mr. Cell Chem Biol. 2024 Feb 15;31(2):326-337.e11. doi: 10.1016/j.chembiol.2023.10.023. Epub 2023 Nov 27. Cell Chem Biol. 2024. PMID: 38016478 Free article.
Dual inhibition of EGFR and PI3K with a single drug.
Katerji M, Rubin MR, Brognard J. Katerji M, et al. Among authors: rubin mr. Nat Cancer. 2024 Aug;5(8):1131-1133. doi: 10.1038/s43018-024-00806-0. Nat Cancer. 2024. PMID: 39152227 No abstract available.
Efficacy and Safety of TransCon PTH in Adults with Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.
Clarke BL, Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Abbott LG, Hofbauer LC, Kohlmeier L, Cetani F, Pihl S, An X, Smith AR, Lai B, Ukena J, Sibley CT, Shu AD, Rejnmark L. Clarke BL, et al. Among authors: rubin mr. J Clin Endocrinol Metab. 2024 Oct 8:dgae693. doi: 10.1210/clinem/dgae693. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39376010
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
Rejnmark L, Gosmanova EO, Khan AA, Makita N, Imanishi Y, Takeuchi Y, Sprague S, Shoback DM, Kohlmeier L, Rubin MR, Palermo A, Schwarz P, Gagnon C, Tsourdi E, Zhao C, Makara MA, Ominsky MS, Lai B, Ukena J, Sibley CT, Shu AD. Rejnmark L, et al. Among authors: rubin mr. Adv Ther. 2024 Jun;41(6):2500-2518. doi: 10.1007/s12325-024-02843-8. Epub 2024 Apr 30. Adv Ther. 2024. PMID: 38691316 Free PMC article. Clinical Trial.
Supporting the democratization of science during a pandemic: genomics Course-based Undergraduate Research Experiences (CUREs) as an effective remote learning strategy.
Lopatto D, Silver Key SC, Van Stry M, Siders J, Leung W, Sandlin KM, Rele CP; Genomics Education Partnership; Reed LK. Lopatto D, et al. J Microbiol Biol Educ. 2023 Sep 22;24(3):e00039-23. doi: 10.1128/jmbe.00039-23. eCollection 2023 Dec. J Microbiol Biol Educ. 2023. PMID: 38230306 Free PMC article.
181 results